series-b
Stage
2018
Founded
3
Investors
About
Triomics develops generative AI solutions for oncology, focusing on cancer care operations and research. The company provides a platform that automates clinical trial matching, pre-visit chart review and preparation, and oncology data abstraction for registries, quality improvement and operational work.
Explore Triomics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.